Biovirtus Research Site Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical Preparation Manufacturing | Book Publishers | Research and Development in the Physical, Engineering, and Life Sciences | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Marketing Research and Public Opinion Polling | Translation and Interpretation Services | Veterinary Services | Management of Companies and Enterprises

Full name: Biovirtus Research Site Sp. z o.o.

Profile Updated: December 02, 2025

Biovirtus Research Site Sp. z o.o operates in the healthcare industry. The company offers clinical trials for healthy volunteers and patients, as well as nursing care through the BioVirtus Medical Center. Biovirtus Research Site Sp. z o.o. focuses on providing these services to its target market.

Headquarters
Ul. Augustyna Locciego 5/2
Warsaw; Mazowieckie; Postal Code: 02-928

Contact Details: Purchase the Biovirtus Research Site Sp. z o.o. report to view the information.

Website: http://www.przychodnia-biovirtus.pl

Basic Information

Total Employees:

Purchase the Biovirtus Research Site Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Biovirtus Research Site Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Biovirtus Research Site Sp. z o.o. report to view the information.

Incorporation Date:

January 18, 2013

Ownership Details

Purchase this report to view the information.

100%

Subsidiaries

Biovirtus Sp. z o.o.

100%

Company Performance

Financial values in the chart are available after Biovirtus Research Site Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-77.86%▼

Total operating revenue

-33.88%▼

Operating Profit/Loss (EBIT)

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

-27.51%▼

Total Equity

N/A

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

-33.87%▼

Quick Ratio

0.63%▲

Similar companies